Skip to main content
. 2018 Sep 28;52(3):190–195. doi: 10.14744/SEMB.2018.75537

Table 2.

Drugs used by patients dependent on the development of contrast-induced nephropathy (CIN)

Drug OVERALL (211) CIN (-) (171) CIN (+) (40) p
ACE inhibitor 99 (46.9) 79 (46.2) 20 (50) 0.66
Calcium channel blocker 57 (27.0) 44 (25.7) 13 (32.5) 0.38
Beta-blocker 108 (51.2) 87 (50.9) 21 (52.5) 0.85
Statin 69 (32.7) 54 (31.6) 15 (37.5) 0.47